Podcast Series

Hear from one of this year’s keynote speakers on the topics he feels are the most crucial in pharma today.

Omar Ali is the Formulary Development Pharmacist for Surrey & Sussex Healthcare NHS Trust and also sits on the External reference Group for Cost Impact Modelling for NICE.

1st in the series:
Value Based Pricing

• How value based pricing will affect pharma on a global scale and how this will affect your products chance of reimbursement
• How therapies will be assessed in order to increase the chances of approval
• What impact VBP will have on innovation initiatives and how you can overcome the challenges created by the new system

2nd in the series:

The New Government White Paper: impact on PCTs, GP Clusters and Consortia

• How payers assess the budget impact of drugs; the utilities and dis-utilities
• The benefits of the new system; more freedom to prescribe, the removal of barriers and increase in autonomy
• The negative impact of this new system; autonomy nightmare? Post code prescribing and the chance of non-approval regardless of new GP powers

Omar may be reached on omar.ali@sash.nhs.uk